Business Description
KAINOS Laboratories Inc
ISIN : JP3205650009
Total Employee Number:
157Description
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.92 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 0.81 | |||||
Interest Coverage | 119.71 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.69 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year EBITDA Growth Rate | -9.6 | |||||
3-Year EPS without NRI Growth Rate | -1.4 | |||||
3-Year FCF Growth Rate | 0.1 | |||||
3-Year Book Growth Rate | 6.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.29 | |||||
9-Day RSI | 45.15 | |||||
14-Day RSI | 49.53 | |||||
3-1 Month Momentum % | -0.31 | |||||
6-1 Month Momentum % | 80.68 | |||||
12-1 Month Momentum % | 83.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.31 | |||||
Quick Ratio | 2.81 | |||||
Cash Ratio | 2.13 | |||||
Days Inventory | 124.28 | |||||
Days Sales Outstanding | 93.8 | |||||
Days Payable | 62.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 0.13 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 47.31 | |||||
Operating Margin % | 13.64 | |||||
Net Margin % | 8.2 | |||||
EBITDA Margin % | 13.56 | |||||
FCF Margin % | 9.96 | |||||
OCF Margin % | 10.11 | |||||
ROE % | 6.43 | |||||
ROA % | 4.94 | |||||
ROIC % | 11.73 | |||||
3-Year ROIIC % | -7.79 | |||||
ROC (Joel Greenblatt) % | 18.08 | |||||
ROCE % | 8.62 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.57 | |||||
PE Ratio without NRI | 17.52 | |||||
Shiller PE Ratio | 18.85 | |||||
Price-to-Owner-Earnings | 18.81 | |||||
PS Ratio | 1.78 | |||||
PB Ratio | 1.38 | |||||
Price-to-Tangible-Book | 1.38 | |||||
Price-to-Free-Cash-Flow | 18.15 | |||||
Price-to-Operating-Cash-Flow | 17.89 | |||||
EV-to-EBIT | 9.99 | |||||
EV-to-EBITDA | 8.61 | |||||
EV-to-Revenue | 1.17 | |||||
EV-to-FCF | 11.72 | |||||
Price-to-GF-Value | 1.77 | |||||
Price-to-Projected-FCF | 0.89 | |||||
Price-to-Median-PS-Value | 1.92 | |||||
Price-to-Graham-Number | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 2.39 | |||||
| Price-to-Net-Cash | 5.4 | |||||
Earnings Yield (Greenblatt) % | 10.01 | |||||
FCF Yield % | 5.48 | |||||
Forward Rate of Return (Yacktman) % | 4.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KAINOS Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 5,479.789 | ||
| EPS (TTM) (円) | 105.161 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.69 | ||
| 3-Year Sortino Ratio | 5.08 | ||
| Volatility % | 75.35 | ||
| 14-Day RSI | 49.53 | ||
| 14-Day ATR (円) | 1.932856 | ||
| 20-Day SMA (円) | 2270.05 | ||
| 12-1 Month Momentum % | 83.31 | ||
| 52-Week Range (円) | 1204 - 2284 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KAINOS Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KAINOS Laboratories Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| 0.0000042553:1 Stock Split | 2026-06-11 | 2,268.00 (+0.00%) | ||
| JPY 3.000000 Cash Dividend | 2025-03-28 | 1,266.00 (-0.16%) | ||
| JPY 32.000000 Cash Dividend | 2025-03-28 | 1,266.00 (-0.16%) |
Show
Entries
KAINOS Laboratories Inc Frequently Asked Questions
What is KAINOS Laboratories Inc(TSE:4556)'s stock price today?
The current price of TSE:4556 is 円2268.00. The 52 week high of TSE:4556 is 円2284.00 and 52 week low is 円1204.00.
When is next earnings date of KAINOS Laboratories Inc(TSE:4556)?
The next earnings date of KAINOS Laboratories Inc(TSE:4556) is .
Does KAINOS Laboratories Inc(TSE:4556) pay dividends? If so, how much?
KAINOS Laboratories Inc(TSE:4556) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on KAINOS Laboratories Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers